BNC Korea Co., Ltd. logo

BNC Korea Co., Ltd. (256840)

Market Open
11 Aug, 06:30
KRX SM KRX SM
2,735. 00
-5
-0.1825%
391.9B Market Cap
- P/E Ratio
- Div Yield
29,108 Volume
- Eps
2,740
Previous Close
Add Transaction
Day Range
2,715 2,760
Year Range
2,050 6,180
Want to track 256840 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

256840 trading today lower at ₩2,735, a decrease of -0.1825% from yesterday's close, completing a monthly increase of 0% or ₩0. Over the past 12 months, 256840 stock lost -39.0869%.
256840 is not paying dividends to its shareholders.
BNC Korea Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jan 25, 2022.
The company's stock is traded on one exchange.

256840 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

BNC Korea Co., Ltd. (256840) FAQ

What is the stock price today?

The current price is ₩2,735.00.

On which exchange is it traded?

BNC Korea Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 256840.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 391.9B.

Has BNC Korea Co., Ltd. ever had a stock split?

BNC Korea Co., Ltd. had 1 splits and the recent split was on Jan 25, 2022.

BNC Korea Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
KR7256840000 ISIN
KR Country
251 Employees
29 Dec 2025 Last Dividend
25 Jan 2022 Last Split
- IPO Date

Overview

BNC Korea Co., Ltd., founded in 2007 and based in Daegu, South Korea, specializes in the research and development, production, and sales of biomaterials. With a focus on creating innovative products for the healthcare and cosmetic industries, the company has established a strong presence both domestically and internationally, exporting its products to 45 countries. Its product portfolio includes a broad range of HA fillers and skin booster fillers designed for cosmetic enhancements, as well as medical devices aimed at improving patient care in surgical procedures.

Products and Services

- Cutegel / Cutegel Lidocaine / FLORE Lidocaine / ChungA-an / CUTEGEL-M / Cutegel Hydro: These products are HA fillers and skin boosters used for temporary facial wrinkle reduction through physical restoration. By restoring volume and moisture, they offer a minimally invasive solution for enhancing skin appearance.

- S-DNA / H-DNA: Specialized formulas designed to rejuvenate the skin by promoting cellular regeneration. These products are tailored for individuals looking for non-surgical options to improve their skin's texture and vitality.

- Hibarry: A medical dressing intended for the treatment of deep-cavity wounds. It has a specific application in surgeries to reduce the adhesion of the spinal cord, showcasing the company's commitment to innovative solutions in medical care.

- GENTA Q: A white collagen sponge designed to protect wounds by preventing contamination. Its primary use is in clinical settings where wound protection and healing are paramount, illustrating the company's contributions to post-operative care.

- Beauty Solutions, Face Mask Gels, Mils Cleansing Foams, and Brightening Peeling Gels: Aside from their medical products, BNC Korea Co., Ltd. also offers a range of cosmetic products, including face masks, cleansing foams, and peeling gels optimized for enhancing skin beauty and health. These products cater to the growing consumer demand for high-quality skincare solutions.

Contact Information

Address: #405, Structure 1
Phone: 82 70 7116 0059